
Sign up to save your podcasts
Or


Does psychiatry want to become almost exclusively focused on biology and medication? We’ll hear Dr. Pies’ perspective on psychiatry as he speaks about his book, titled Psychiatry at the Crossroads: Can Psychiatry Find the Path to a Truly Humanistic Science? Tune in with Dr. Andrew Wilner and Dr. Ronald Pies, Professor Emeritus of Psychiatry at State University of New York Upstate Medical University and a Clinical Professor of Psychiatry at Tufts University School of Medicine.
Alzheimer’s disease is the most common form of dementia, and symptoms become more severe over time. In fact, it’s the leading cause of disability and poor health in older adults. And although there’s no cure, a new medication called lecanemab recently received accelerated approval by the US Food and Drug Administration. So what might this new development mean for the 6 million Americans living with this debilitating disease? Find out as Dr. Andrew Wilner speaks with fellow ReachMD host Dr. David Weisman, who’s also the Director of Clinical Research at Abington Neurological Associates.
In an age where there’s an app for everything, are smartphone apps and other technology-enable solutions revolutionizing mental health treatment in patients with GI challenges? Dr. Neil Nandi speaks with Dr. Megan Riehl from the University of Michigan to explore the capabilities of these technologies and their role in treatment.
Due to the nature of their work, first responders may be at a higher risk for developing posttraumatic stress disorder (PTSD). So how can clinicians help their front-line patients with PTSD? Dr. Andrew Wilner will discuss this with Dr. Marilyn Wooley, Clinical Psychologist who specializes in treating first responders and author of the book, How Heroes Heal: Stories of First Responders and the Journey from Posttraumatic Stress Injury to Posttraumatic Growth.
Eye movement desensitization and reprocessing (EMDR) therapy is an interactive psychotherapy used to relieve stress and reduce symptoms of trauma. It is most commonly associated with the treatment of posttraumatic stress disorder (PTSD). But can this therapy also treat other stress-related disorders? To go into further detail, Dr. Charles Turck is joined by Dr. Deborah Korn, a clinical psychologist in private practice in Cambridge, Massachusetts and co-author of the book titled Every Memory Deserves Respect: EMDR, the Proven Trauma Therapy with the Power to Heal.
Have our patients experienced anxiety, depression, and stress following a COVID-19 infection? Joining Mario Nacinovich to dive into emerging research on post-COVID-19 psychological distress is Dr. Siwen Wang, a researcher in the Department of Nutrition at Harvard T.H. Chan School of Public Health.
Current screening tools for postpartum depression may have limitations, but a new texting service as part of the Healing at Home program may help clinicians detect postpartum depression earlier. Dr. Charles Turck is joined by Dr. Kirstin Leitner to take a look at this program and its impacts.
Although we’ve made some progress in the treatment of schizophrenia, unmet needs still remain. So what are the new mechanism of actions being explored in the treatment of this disease? To learn more about the updates featured at the 2022 Psych Congress, Dr. Charles Turck speaks with Dr. Craig Chepke, Medical Director of Excel Psychiatric Associates and member of the Psych Congress Steering Committee.
Schizophrenia is a chronic mental disorder characterized by symptoms that negatively affect a patient’s mental and emotional behaviors. And although there are current treatment options including first and second-generation antipsychotics, treatment challenges still persist. That’s why Dr. Andrew Wilner speaks to psychiatrist Dr. Craig Chepke from Excel Psychiatric Associates to discuss clinical strategies that can help optimize outcomes for our patients.
Hypertension affects nearly half of adults in the United States and is associated with cognitive decline and dementia. A wide variety of antihypertensive medications are prescribed to millions of people to control blood pressure and prevent vascular dementia. Could it be that certain medications are better than others in preventing brain injury from chronic hypertension? Dr. Andrew Wilner is joined by Dr. Zachary Marcum, Associate Professor in the School of Pharmacy-University of Washington, to discuss his recent study investigating the association between certain hypertension medications and reduced cognitive impairment.